The Fibroblast Growth Factor Receptor: A New Potential Target for the Treatment of Breast Cancer Esther ZamoraEva Muñoz-CouseloJose Perez-Garcia Systemic Therapy (J Cortes, Section Editor) 04 January 2014 Pages: 51 - 58
The PI3K/AKT/MTOR Signaling Pathway: The Role of PI3K and AKT Inhibitors in Breast Cancer Florian HuemerRupert BartschMichael Gnant Systemic Therapy (J Cortes, Section Editor) 31 January 2014 Pages: 59 - 70
Importance of Breast Cancer Subtype in the Development of Androgen-Receptor-Directed Therapy Elgene LimMin NiMyles Brown Systemic Therapy (J Cortes, Section Editor) 13 February 2014 Pages: 71 - 78
Cyclin Kinase Inhibitors in Breast Cancer: From Bench to Bedside Gabriela TorresIsabel EchavarríaMiguel Martin Systemic Therapy (J Cortes, Section Editor) 10 April 2014 Pages: 79 - 87
Targets for the Action of Phytoestrogens in Breast Cancer—Focus on Isoflavones and Resveratrol Suman RiceSaffron Ann Whitehead Risk, Prevention, and Screening (TA Patel, Section Editor) 22 March 2014 Pages: 88 - 95
Advances in Preventive Therapy for Estrogen-Receptor-Negative Breast Cancer Beate C. LitzenburgerPowel H. Brown Risk, Prevention, and Screening (TA Patel, Section Editor) Open access 25 March 2014 Pages: 96 - 109
Understanding Drug Resistance in Breast Cancer with Mathematical Oncology Terisse BrocatoPrashant DograVittorio Cristini Risk, Prevention, and Screening (TA Patel, Section Editor) 02 April 2014 Pages: 110 - 120
Use of Exogenous Hormones and Risks of Breast and Ovarian Cancers in BRCA1/2 Mutation Carriers; Methodological and Clinical Considerations Lieske H. SchrijverSusanne JansenMatti A. Rookus Risk, Prevention, and Screening (TA Patel, Section Editor) 02 May 2014 Pages: 121 - 131
Breast Tomosynthesis: a Replacement or an Adjunct to Conventional Diagnostic Mammography? Jaime L. GeiselLiane E. Philpotts Risk, Prevention, and Screening (TA Patel, Section Editor) 30 March 2014 Pages: 132 - 137